Madan Jagasia, MBBS, MS, on Ruxolitinib to Treat Steroid Refractory GvHD

Madan Jagasia, MBBS, MS, of the Vanderbilt University Medical Center discussed the next steps in treating acute graft versus host disease with ruxolitinib.

Source: CancerNetwork - March 5, 2020 Category: Cancer & Oncology Authors: Madan Jagasia, MBBS, MS Source Type: news